Form 8-K - Current report:
SEC Accession No. 0001193125-26-318263
Filing Date
2026-07-27
Accepted
2026-07-27 17:08:53
Documents
3
Period of Report
2026-07-27
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d141508d8k.htm 8-K 18098
2 EX-3.1 d141508dex31.htm EX-3.1 27630
3 EX-3.2 d141508dex32.htm EX-3.2 173757
  Complete submission text file 0001193125-26-318263.txt   220672
Mailing Address 1150 MARINA VILLAGE PKWY ALAMEDA CA 94501
Business Address 1150 MARINA VILLAGE PKWY ALAMEDA CA 94501 510-454-0213
Scribe Therapeutics, Inc. (Filer) CIK: 0001853921 (see all company filings)

EIN.: 822157847 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-43409 | Film No.: 261206619
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)